METIMEDI
Live / Registered — Registered (as of 23 Jun 2020)
What this means for you
Registered since 23 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88693805
- Registration number
- 6084402
- Mark type
- Stylized text
- Filed
- 15 Nov 2019
- Published for opposition
- 07 Apr 2020
- Registered
- 23 Jun 2020
- Attorney of record
- N. Christopher Norton
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for immunity adjustment; Vaccines; Pharmaceutical agents for regenerating cells; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; Chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemico-pharmaceutical preparations, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Pharmaceuticals for medical purposes for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Antibacterial substances for medical purposes; Antibodies for medical purposes for the treatment of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemical preparations for medical purpose, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic kits for medical diagnostic purposes comprising reagents for use in disease testing, health monitoring and more generally, predictive and preventive medicine in the fields of detecting immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic pharmaceutical preparations for medical purposes; Antibiotics; Tumor suppressing agents; Chemotherapeutics
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines; Crude medicines research; Medical and scientific research on adult diseases; Medical and scientific research on cancer; Pharmaceutical products development; Research on the subject of pharmaceuticals; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research for medical products; Medical research; Chemistry services, namely, chemistry consultation, research in the field of chemistry, laboratory research and analysis in the field of chemistry; Chemical research and analysis; Research and development of medical products for others
Owner
- MetiMedi Pharmaceuticals Co., Ltd., Incheon, KR
- MetiMedi Pharmaceuticals Co., Ltd., Incheon, KR
- MetiMedi Pharmaceuticals Co., Ltd., Incheon, KR
Prosecution history
- 23 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Mar 2022 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 17 Mar 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 17 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 15 Apr 2020 — WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
- 13 Apr 2020 — TEAS DELETE 1(B) BASIS RECEIVED
- 07 Apr 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Apr 2020 — PUBLISHED FOR OPPOSITION
- 18 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Mar 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 04 Mar 2020 — POST PUBLICATION AMENDMENT - ENTERED
- 02 Mar 2020 — ASSIGNED TO LIE